Related by context. Frequent words. (Click for all words.) 73 familial hypercholesterolemia 68 myelodysplastic syndrome MDS 68 severe renal impairment 68 elevated triglycerides 68 hypercalcemia 68 tolvaptan 67 primary pulmonary hypertension 67 lupus nephritis 67 non alcoholic steatohepatitis 67 intermittent claudication 67 hypercholesterolemia 66 tumor lysis syndrome 66 mixed dyslipidemia 66 relapsing remitting 66 pulmonary arterial hypertension 66 Phenoptin 65 phenylketonuria 65 secondary hyperparathyroidism 65 optic neuropathy 65 Ulcerative colitis 65 Torisel 65 anakinra 65 Ischemic 65 blood clotting disorder 65 Pivotal Phase III 65 von Willebrand disease 65 Thrombocytopenia 65 lipid disorders 65 diabetic neuropathic pain 65 systemic lupus erythematosus 65 hyperkalemia 65 pancreatic insufficiency 65 carcinoid syndrome 64 pulmonary arterial hypertension PAH 64 pheochromocytoma 64 Combination therapy 64 hypoparathyroidism 64 darapladib 64 azacitidine 64 Bevacizumab 64 medullary thyroid cancer 64 pseudobulbar affect PBA 64 eltrombopag 64 idiopathic pulmonary fibrosis IPF 64 PREZISTA r 63 ISIS # 63 mycophenolate mofetil 63 Pioglitazone 63 AA amyloidosis 63 gastrointestinal stromal tumors 63 macular edema 63 myelodysplastic syndromes MDS 63 squalamine 63 systemic lupus erythematosus SLE 63 chronic HCV infection 63 postherpetic neuralgia 63 chronic lymphocytic leukemia CLL 63 hyperparathyroidism 63 heavily pretreated 63 diabetic nephropathy 63 6R BH4 63 fingolimod 63 amnestic mild cognitive impairment 63 alvimopan 63 relapsing remitting multiple sclerosis 63 hypertriglyceridemia 63 aHUS 63 Zolinza 63 Gemzar ® 63 Retinopathy 63 postherpetic neuralgia PHN 63 lactic acidosis 62 elotuzumab 62 hemolytic anemia 62 Hypoglycemia 62 temsirolimus 62 angioedema 62 ischemic cardiomyopathy 62 hypersensitivity reaction 62 Topiramate 62 PsA 62 Pivotal Phase 62 paroxysmal nocturnal hemoglobinuria PNH 62 Pivotal Trial 62 leukopenia 62 hyperuricemia 62 tocilizumab 62 autosomal dominant 62 hemorrhagic strokes 62 Keppra R 62 Asymptomatic 62 Alemtuzumab 62 myelodysplastic syndromes 62 hepatic impairment 62 chronic ITP 62 mipomersen 62 atherothrombosis 62 J Am Coll 62 neovascular AMD 62 hyperbilirubinemia 62 mTOR inhibitor